Literature DB >> 9141706

Antigenic polymorphism of the lipopolysaccharides from human and animal isolates of Bordetella bronchiseptica.

Karine Le Blay1, Pascale Gueirard2, Nicole Guiso2, Richard Chaby1.   

Abstract

Six monoclonal antibodies (mAbs) against lipopolysaccharides (LPS) from Bordetella pertussis (P1P3, 60.5), B. parapertussis (PP2, PP6, PPB) and B. bronchiseptica (BRg1) were used to examine the presence of antigenic determinants of LPS on B. bronchiseptica cells. Forty-eight clinical isolates of this Gram-negative bacterium (4 canine, 3 equine, 6 porcine, 4 rabbit and 31 human) were examined. Significant cross-reactivities with the heterologous anti-pertussis and anti-parapertussis mAbs were observed. The isolates also exhibited marked antigenic polymorphism. The 48 isolates could be classified in six immunogroups. Purified LPS preparations extracted from some isolates were analysed by ELISA, thin-layer chromatography, and tricine-SDS-PAGE. The results show that four main types of antigenic polymorphism of B. bronchiseptica LPSs exist: (a) heterogeneity of the core, (b) presence or absence of O-chains, (c) differences in the hinge region between O-chain and core, and (d) differences in interactions of LPS with other cell-surface constituents. Smooth-type LPS molecules, detectable with mAb PP6, were more frequently observed in animal isolates (94%) than in human isolates (52%). Reverse frequencies were found with mAb 60.5 (48% of human isolates, 18% of animal isolates), which is unable to react with long-chain LPSs. This observation could be due to the general absence of some lectin-like receptor, specific to the O-chain, on human bronchoalveolar tissues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9141706     DOI: 10.1099/00221287-143-4-1433

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  13 in total

1.  Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Mylisa R Parette; Sara E Hester; Julian Parkhill; Eric T Harvill
Journal:  J Bacteriol       Date:  2008-06-13       Impact factor: 3.490

2.  Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection.

Authors:  Paul B Mann; Daniel Wolfe; Eicke Latz; Douglas Golenbock; Andrew Preston; Eric T Harvill
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Laboratory adaptation of Bordetella pertussis is associated with the loss of type three secretion system functionality.

Authors:  M E Gaillard; D Bottero; C E Castuma; L A Basile; D Hozbor
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

4.  Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Laura S Weyrich; Eric T Harvill
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

5.  Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection.

Authors:  E T Harvill; A Preston; P A Cotter; A G Allen; D J Maskell; J F Miller
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  In vitro and in vivo characterization of a Bordetella bronchiseptica mutant strain with a deep rough lipopolysaccharide structure.

Authors:  Federico Sisti; Julieta Fernández; María Eugenia Rodríguez; Antonio Lagares; Nicole Guiso; Daniela Flavia Hozbor
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides.

Authors:  A Banemann; H Deppisch; R Gross
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome.

Authors:  A Tizolova; N Guiso; S Guillot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-12       Impact factor: 3.267

9.  Comparison of bipA alleles within and across Bordetella species.

Authors:  Bryna Fuchslocher; Laura L Millar; Peggy A Cotter
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Structural characterization of Bordetella parapertussis lipid A.

Authors:  Asmaa El Hamidi; Alexey Novikov; Doris Karibian; Malcolm B Perry; Martine Caroff
Journal:  J Lipid Res       Date:  2008-11-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.